Thomas Claringbold, D.O Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1509 N Mcewan St, Suite 3, Clare, MI 48617 Phone: 989-802-8811 Fax: 989-802-8809 |
News Archive
Scientists at the University of Edinburgh are closer to correcting an abnormal gene which causes one of the crippling muscle wasting diseases known collectively as Charcot-Marie-Tooth (CMT) disease.
Scientists from the U.S. Department of Energy's (DOE) Argonne National Laboratory and the University of Chicago's Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to soft biological material.
EU-funded researchers have taken the firsts steps towards future technologies combining silicon circuits and the nervous systems of mammals. Applications could include advanced drug screening and, perhaps one day, implants to help combat neurological disorders.
A Food and Drug Administration investigation last year found that Masimo Corp. did not adequately look into reports of problems with its devices, ProPublica reports, even though the company owner, Joe Kiani, has created a foundation dedicated to eliminating medical mistakes. In addition, the Boston Globe examines how medical technology companies are looking for new strategies to boost sales.
› Verified 9 days ago